Bellevue Group AG - Q1 2018 holdings

$1.01 Billion is the total value of Bellevue Group AG's 124 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 16.4% .

 Value Shares↓ Weighting
ALGN SellALIGN TECHNOLOGY INC$40,529,000
+5.1%
161,388
-7.0%
4.02%
-0.4%
ANTM  ANTHEM INC$39,819,000
-2.4%
181,2430.0%3.94%
-7.4%
CELG BuyCELGENE CORP$38,753,000
-8.1%
434,400
+7.5%
3.84%
-12.9%
ISRG SellINTUITIVE SURGICAL INC$34,096,000
-2.8%
82,590
-14.1%
3.38%
-7.8%
ABT BuyABBOTT LABS$33,855,000
+11.9%
565,000
+6.6%
3.35%
+6.1%
UNH SellUNITEDHEALTH GROUP INC$30,514,000
-3.1%
142,590
-0.2%
3.02%
-8.1%
ILMN SellILLUMINA INC$30,090,000
-8.1%
127,273
-15.1%
2.98%
-12.9%
MDT BuyMEDTRONIC PLC$28,639,000
+63.4%
357,000
+64.5%
2.84%
+54.9%
EW BuyEDWARDS LIFESCIENCES CORP$27,508,000
+29.7%
197,160
+4.8%
2.72%
+23.0%
DXCM BuyDEXCOM INC$26,430,000
+72.7%
356,390
+33.6%
2.62%
+63.7%
JAZZ SellJAZZ PHARMACEUTICALS PLC$22,909,000
+9.4%
151,722
-2.5%
2.27%
+3.7%
HUM BuyHUMANA INC$22,501,000
+172.0%
83,700
+151.0%
2.23%
+158.0%
TDOC BuyTELADOC INC$20,782,000
+1168.7%
515,694
+997.2%
2.06%
+1104.1%
DHR  DANAHER CORP DEL$19,778,000
+5.5%
202,0000.0%1.96%0.0%
INCY SellINCYTE CORP$19,218,000
-12.4%
230,626
-0.4%
1.90%
-16.9%
BSX  BOSTON SCIENTIFIC CORP$19,015,000
+10.2%
696,0000.0%1.88%
+4.5%
ABC BuyAMERISOURCEBERGEN CORP$18,550,000
-4.2%
215,178
+2.0%
1.84%
-9.1%
SYK BuySTRYKER CORP$18,232,000
+29.0%
113,300
+24.1%
1.81%
+22.3%
HOLX  HOLOGIC INC$18,078,000
-12.6%
483,8940.0%1.79%
-17.1%
WBA SellWALGREENS BOOTS ALLIANCE INC$17,255,000
-19.9%
263,560
-11.1%
1.71%
-24.0%
VRTX BuyVERTEX PHARMACEUTICALS INC$15,778,000
+9.4%
96,810
+0.6%
1.56%
+3.8%
ALXN BuyALEXION PHARMACEUTICALS INC$14,645,000
-6.4%
131,390
+0.5%
1.45%
-11.2%
MGNX SellMACROGENICS INC$14,169,000
+32.1%
563,151
-0.2%
1.40%
+25.4%
BAX  BAXTER INTL INC$14,049,000
+0.6%
216,0000.0%1.39%
-4.6%
IONS BuyIONIS PHARMACEUTICALS INC$13,761,000
+6.6%
312,186
+21.6%
1.36%
+1.1%
HRC SellHILL ROM HLDGS INC$13,739,000
-4.1%
157,919
-7.1%
1.36%
-9.0%
SUPN BuySUPERNUS PHARMACEUTICALS INC$13,227,000
+38.1%
288,800
+20.1%
1.31%
+30.9%
CNC BuyCENTENE CORP DEL$12,827,000
+10.2%
120,020
+4.0%
1.27%
+4.5%
KTWO NewK2M GROUP HLDGS INC$12,657,000667,941
+100.0%
1.25%
BIIB SellBIOGEN INC$12,650,000
-24.1%
46,200
-11.7%
1.25%
-28.0%
GILD SellGILEAD SCIENCES INC$12,605,000
-2.8%
167,200
-7.7%
1.25%
-7.8%
ESPR BuyESPERION THERAPEUTICS INC NEW$12,493,000
+2330.5%
172,720
+2114.4%
1.24%
+2192.6%
FIT NewFITBIT INCcl a$11,707,0002,295,400
+100.0%
1.16%
AMGN SellAMGEN INC$11,712,000
-17.6%
68,700
-16.0%
1.16%
-21.9%
BDX SellBECTON DICKINSON & CO$10,835,000
-8.0%
50,000
-9.1%
1.07%
-12.8%
WMGI  WRIGHT MED GROUP NV$10,749,000
-10.6%
541,8010.0%1.06%
-15.3%
IART BuyINTEGRA LIFESCIENCES HLDGS C$10,570,000
+21.2%
191,000
+4.8%
1.05%
+14.9%
RMD BuyRESMED INC$10,536,000
+164.7%
107,000
+127.7%
1.04%
+151.0%
CI  CIGNA CORPORATION$9,670,000
-17.4%
57,6500.0%0.96%
-21.7%
LH BuyLABORATORY CORP AMER HLDGS$9,661,000
+6.6%
59,730
+5.1%
0.96%
+1.1%
MYL SellMYLAN N V$9,632,000
-3.7%
233,950
-1.0%
0.95%
-8.6%
REGN SellREGENERON PHARMACEUTICALS$9,429,000
-9.8%
27,380
-1.5%
0.93%
-14.5%
ZBH  ZIMMER BIOMET HLDGS INC$9,050,000
-9.6%
83,0000.0%0.90%
-14.2%
HCM BuyHUTCHISON CHINA MEDITECH LTDsponsored adr$8,940,000
+70.0%
302,420
+125.9%
0.89%
+61.4%
ALDR BuyALDER BIOPHARMACEUTICALS INC$8,896,000
+2441.7%
700,464
+2189.1%
0.88%
+2281.1%
SHPG BuySHIRE PLCsponsored adr$8,730,000
-0.3%
58,435
+3.5%
0.86%
-5.5%
LIVN SellLIVANOVA PLC$8,383,000
-28.8%
94,724
-35.7%
0.83%
-32.4%
TSRO BuyTESARO INC$8,274,000
+38.5%
144,802
+100.8%
0.82%
+31.4%
ABMD BuyABIOMED INC$7,929,000
+56.7%
27,250
+0.9%
0.79%
+48.6%
INSM NewINSMED INC$7,533,000334,489
+100.0%
0.75%
BGNE SellBEIGENE LTDsponsored adr$6,829,000
-32.6%
40,650
-60.8%
0.68%
-36.0%
GNMK BuyGENMARK DIAGNOSTICS INC$6,455,000
+100.1%
1,186,502
+53.4%
0.64%
+89.9%
COO  COOPER COS INC$5,102,000
+5.1%
22,3000.0%0.50%
-0.4%
TMO SellTHERMO FISHER SCIENTIFIC INC$4,924,000
+0.5%
23,848
-7.6%
0.49%
-4.7%
NBIX SellNEUROCRINE BIOSCIENCES INC$4,449,000
+5.2%
53,650
-1.6%
0.44%
-0.2%
NKTR SellNEKTAR THERAPEUTICS$3,772,000
-15.4%
35,500
-52.5%
0.37%
-19.7%
CERN BuyCERNER CORP$3,712,000
+25.2%
64,000
+45.5%
0.37%
+18.7%
BMRN SellBIOMARIN PHARMACEUTICAL INC$3,595,000
-10.5%
44,350
-1.6%
0.36%
-15.2%
TFX  TELEFLEX INC$3,570,000
+2.5%
14,0000.0%0.35%
-2.7%
MOH  MOLINA HEALTHCARE INC$3,531,000
+5.8%
43,5000.0%0.35%
+0.3%
ESRX  EXPRESS SCRIPTS HLDG CO$3,419,000
-7.5%
49,5000.0%0.34%
-12.2%
AGIO SellAGIOS PHARMACEUTICALS INC$3,296,000
+41.0%
40,300
-1.5%
0.33%
+34.0%
ALKS SellALKERMES PLC$2,950,000
+4.2%
50,900
-1.5%
0.29%
-1.4%
HSIC  SCHEIN HENRY INC$2,890,000
-3.8%
43,0000.0%0.29%
-8.9%
PRGO  PERRIGO CO PLC$2,750,000
-4.4%
33,0000.0%0.27%
-9.6%
LGND SellLIGAND PHARMACEUTICALS INC$2,750,000
-20.9%
16,650
-34.4%
0.27%
-25.1%
XRAY  DENTSPLY SIRONA INC$2,742,000
-23.6%
54,5000.0%0.27%
-27.5%
ALNY SellALNYLAM PHARMACEUTICALS INC$2,590,000
-7.8%
21,750
-1.6%
0.26%
-12.3%
JNJ SellJOHNSON & JOHNSON$2,563,000
-29.5%
20,000
-23.1%
0.25%
-33.2%
SGEN SellSEATTLE GENETICS INC$2,557,000
-10.7%
48,850
-8.7%
0.25%
-15.4%
BMY NewBRISTOL MYERS SQUIBB CO$2,530,00040,000
+100.0%
0.25%
GMED  GLOBUS MED INCcl a$2,434,000
+21.2%
48,8500.0%0.24%
+14.8%
BLUE SellBLUEBIRD BIO INC$2,271,000
-33.2%
13,300
-30.4%
0.22%
-36.6%
TRHC  TABULA RASA HEALTHCARE INC$2,250,000
+38.3%
58,0000.0%0.22%
+31.2%
AGN SellALLERGAN PLC$2,188,000
-18.9%
13,000
-21.2%
0.22%
-23.0%
IRTC  IRHYTHM TECHNOLOGIES INC$2,103,000
+12.3%
33,4000.0%0.21%
+6.1%
HCA  HCA HEALTHCARE INC$2,066,000
+10.4%
21,3000.0%0.20%
+5.1%
RARE SellULTRAGENYX PHARMACEUTICAL INC$2,055,000
+8.3%
40,300
-1.5%
0.20%
+3.0%
SAGE SellSAGE THERAPEUTICS INC$2,005,000
-3.8%
12,450
-1.6%
0.20%
-8.7%
ICPT BuyINTERCEPT PHARMACEUTICALS IN$1,962,000
+73.2%
31,900
+64.4%
0.19%
+64.4%
MCK  MCKESSON CORP$1,944,000
-9.7%
13,8000.0%0.19%
-14.2%
PEN  PENUMBRA INC$1,943,000
+22.9%
16,8000.0%0.19%
+16.4%
ITCI SellINTRA CELLULAR THERAPIES INC$1,916,000
+43.1%
91,000
-1.6%
0.19%
+35.7%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$1,876,000
+82.3%
94,500
+71.8%
0.19%
+73.8%
ANGO  ANGIODYNAMICS INC$1,754,000
+3.7%
101,7000.0%0.17%
-1.7%
EGRX  EAGLE PHARMACEUTICALS INC$1,739,000
-1.4%
33,0000.0%0.17%
-6.5%
NUVA  NUVASIVE INC$1,687,000
-10.7%
32,3120.0%0.17%
-15.2%
CHRS  COHERUS BIOSCIENCES INC$1,658,000
+25.6%
150,0000.0%0.16%
+18.8%
HCSG  HEALTHCARE SVCS GRP INC$1,652,000
-17.5%
38,0000.0%0.16%
-21.5%
CLLS BuyCELLECTIS S Asponsored ads$1,642,000
+131.3%
52,100
+114.0%
0.16%
+120.3%
VRX NewVALEANT PHARMACEUTICALS INTL$1,592,000100,000
+100.0%
0.16%
PODD  INSULET CORP$1,560,000
+25.6%
18,0000.0%0.16%
+19.2%
TEVA SellTEVA PHARMACEUTICAL INDS LTDsponsored adr$1,538,000
-87.9%
90,000
-86.6%
0.15%
-88.6%
AET SellAETNA INC NEW$1,521,000
-61.7%
9,000
-59.1%
0.15%
-63.6%
XENT  INTERSECT ENT INC$1,510,000
+21.3%
38,4300.0%0.15%
+15.4%
MASI  MASIMO CORP$1,495,000
+3.7%
17,0000.0%0.15%
-2.0%
HALO SellHALOZYME THERAPEUTICS INC$1,485,000
-4.8%
75,800
-1.6%
0.15%
-9.8%
IPXL  IMPAX LABORATORIES INC$1,459,000
+16.8%
75,0000.0%0.14%
+11.5%
QTRX  QUANTERIX CORP$1,428,000
-20.6%
83,8000.0%0.14%
-25.0%
PTLA SellPORTOLA PHARMACEUTICALS INC$1,395,000
-33.9%
42,700
-1.5%
0.14%
-37.3%
AKCA NewAKCEA THERAPEUTICS INC$1,250,00048,799
+100.0%
0.12%
CAH  CARDINAL HEALTH INC$1,254,000
+2.4%
20,0000.0%0.12%
-3.1%
RDUS SellRADIUS HEALTH INC$1,197,000
+11.5%
33,300
-1.5%
0.12%
+6.2%
PRTA SellPROTHENA CORP PLC$1,133,000
-3.6%
30,850
-1.6%
0.11%
-8.9%
EXEL SellEXELIXIS INC$1,103,000
-28.3%
49,800
-1.6%
0.11%
-32.3%
PFE  PFIZER INC$1,036,000
-2.1%
29,2000.0%0.10%
-7.2%
CLVS SellCLOVIS ONCOLOGY INC$937,000
-23.4%
17,750
-1.4%
0.09%
-27.3%
GKOS  GLAUKOS CORP$925,000
+20.1%
30,0000.0%0.09%
+15.0%
NVRO  NEVRO CORP$927,000
+25.4%
10,7000.0%0.09%
+19.5%
HMSY  HMS HLDGS CORP$901,000
-0.7%
53,5000.0%0.09%
-6.3%
OMCL  OMNICELL INC$868,000
-10.5%
20,0000.0%0.09%
-14.9%
VAR  VARIAN MED SYS INC$859,000
+10.4%
7,0000.0%0.08%
+4.9%
ACAD SellACADIA PHARMACEUTICALS INC$776,000
-26.4%
34,550
-1.4%
0.08%
-30.0%
COTV  COTIVITI HLDGS INC$748,000
+7.0%
21,7080.0%0.07%
+1.4%
MRK SellMERCK & CO INC$681,000
-56.0%
12,500
-54.5%
0.07%
-58.6%
MDCO SellMEDICINES CO$580,000
+18.9%
17,600
-1.4%
0.06%
+11.8%
GWPH SellGW PHARMACEUTICALS PLCads$549,000
-15.9%
4,875
-1.5%
0.05%
-20.6%
CVS  CVS HEALTH CORP$547,000
-14.3%
8,8000.0%0.05%
-19.4%
SGRY  SURGERY PARTNERS INC$532,000
+41.9%
31,0000.0%0.05%
+35.9%
QTNT  QUOTIENT LTD$518,000
-5.0%
110,0000.0%0.05%
-10.5%
AACH SellAAC HLDGS INC$502,000
+24.0%
43,700
-2.9%
0.05%
+19.0%
ENDP SellENDO INTL PLC$369,000
-24.7%
62,200
-1.6%
0.04%
-27.5%
MYGN SellMYRIAD GENETICS INC$349,000
-15.3%
11,800
-1.7%
0.04%
-18.6%
EARS SellAURIS MED HLDG AG$347,000
-72.9%
216,963
-90.0%
0.03%
-74.6%
TBPH ExitTHERAVANCE BIOPHARMA INC$0-10,628
-100.0%
-0.03%
OBLN ExitOBALON THERAPEUTICS INC$0-48,000
-100.0%
-0.03%
ACHC ExitACADIA HEALTHCARE COMPANY IN$0-10,000
-100.0%
-0.03%
EVHC ExitENVISION HEALTHCARE CORP$0-13,026
-100.0%
-0.05%
MLNT ExitMELINTA THERAPEUTICS INC$0-32,100
-100.0%
-0.05%
BIVV ExitBIOVERATIV INC$0-10,200
-100.0%
-0.06%
INO ExitINOVIO PHARMACEUTICALS INC$0-140,100
-100.0%
-0.06%
IBB ExitISHARES TRnasdaq biotech$0-13,500
-100.0%
-0.15%
QGEN ExitQIAGEN NV$0-56,611
-100.0%
-0.18%
ABBV ExitABBVIE INC$0-19,500
-100.0%
-0.20%
JUNO ExitJUNO THERAPEUTICS INC$0-41,900
-100.0%
-0.20%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-17,200
-100.0%
-0.27%
LABU ExitDIREXION SHS ETF TRsp biotch bl new$0-38,400
-100.0%
-0.31%
THC ExitTENET HEALTHCARE CORP$0-616,796
-100.0%
-0.98%
HZNP ExitHORIZON PHARMA PLC$0-794,062
-100.0%
-1.21%
LLY ExitLILLY ELI & CO$0-241,262
-100.0%
-2.13%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Bellevue Asset Management AG #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-05-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IONIS PHARMACEUTICALS INC31Q3 20239.3%
Vertex Pharmaceuticals Incorporated31Q3 20235.9%
NEUROCRINE BIOSCIENCES INC31Q3 20235.7%
Incyte Corporation31Q3 20235.4%
INTUITIVE SURGICAL INC31Q3 20234.7%
ABBOTT LABS31Q3 20234.6%
ELEVANCE HEALTH INC31Q3 20234.3%
UnitedHealth Group Incorporated31Q3 20233.6%
ALNYLAM PHARMACEUTICALS INC31Q3 20233.7%
Boston Scientific Corporation31Q3 20232.5%

View Bellevue Group AG's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G2023-02-14
SC 13G2023-02-14
13F-HR2022-11-14

View Bellevue Group AG's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1009378000.0 != 1009379000.0)

Export Bellevue Group AG's holdings